VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $484,299,000 | +46.0% | 20,839,035 | 0.0% | 9.89% | +36.4% |
Q1 2018 | $331,757,000 | -23.4% | 20,839,035 | 0.0% | 7.25% | -14.2% |
Q4 2017 | $433,035,000 | +45.0% | 20,839,035 | 0.0% | 8.45% | +57.7% |
Q3 2017 | $298,623,000 | -20.9% | 20,839,035 | -4.5% | 5.36% | +5.1% |
Q2 2017 | $377,372,000 | +76.5% | 21,813,400 | +12.5% | 5.10% | +79.8% |
Q1 2017 | $213,811,000 | -24.0% | 19,384,500 | 0.0% | 2.84% | -20.0% |
Q4 2016 | $281,463,000 | -39.2% | 19,384,500 | +2.7% | 3.55% | -29.4% |
Q3 2016 | $463,283,000 | +20.6% | 18,871,000 | -1.1% | 5.02% | +28.6% |
Q2 2016 | $384,110,000 | +8.0% | 19,072,000 | +41.0% | 3.90% | +48.5% |
Q1 2016 | $355,779,000 | -73.6% | 13,527,700 | +2.0% | 2.63% | -67.4% |
Q4 2015 | $1,348,479,000 | -15.0% | 13,265,900 | +49.2% | 8.06% | -2.1% |
Q3 2015 | $1,585,798,000 | -20.7% | 8,890,000 | -1.2% | 8.23% | -10.7% |
Q2 2015 | $1,999,350,000 | +391.0% | 9,000,000 | +339.0% | 9.22% | +344.8% |
Q1 2015 | $407,171,000 | +446.4% | 2,050,000 | +293.7% | 2.07% | +438.4% |
Q4 2014 | $74,517,000 | +9.1% | 520,700 | 0.0% | 0.38% | +35.6% |
Q3 2014 | $68,316,000 | +8.3% | 520,700 | +4.1% | 0.28% | +4.0% |
Q2 2014 | $63,098,000 | -52.1% | 500,300 | -50.0% | 0.27% | -57.7% |
Q1 2014 | $131,830,000 | – | 1,000,000 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |